Literature DB >> 2458251

Differential response of substance P-containing subtypes of adrenomedullary cells to different stressors.

R Vaupel1, H Jarry, H T Schlömer, W Wuttke.   

Abstract

Adrenal medullary cells produce not only the catecholamines norepinephrine and epinephrine but also a number of peptides; hence, they can be subclassified according to their peptide quality. The present study was an attempt to test whether different stressors address different subclasses of adrenal medullary cells. The adrenal gland of intact male rats was implanted with a dialysis system, and the jugular vein was catheterized. One day after surgery, the adrenal dialysis system was connected to a perfusion pump, and Ringer solution was used for dialysis; dialysate fractions were collected at 15-min intervals, and blood was withdrawn at the end of each fraction period after a 2-h equilibration period. The basal release rates of pituitary PRL and adrenal corticosterone, measured in plasma, and of epinephrine, norepinephrine, and substance P (SP) measured in the adrenal dialysates, were constant during the preshock period. SP concentrations in the blood were below the detection limit of the RIA. Application of mild electric foot shock stress resulted in a marked increase in adrenal catecholamine and SP release. Plasma PRL and corticosterone levels also rose during the time of exposure to foot shock, but plasma SP concentrations remained at undetectable values. In contrast, a metabolic stress i.e. insulin-induced hypoglycemia, did not affect adrenal SP release, although adrenal catecholamine release increased to a larger degree than after foot shock stress. Plasma PRL and corticosterone levels also increased during insulin-induced hypoglycemia. It is concluded that an exogenous stressor (electric foot shock) activates adrenomedullary cells containing catecholamines and SP, whereas these cells are not activated by the stress of insulin-induced hypoglycemia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2458251     DOI: 10.1210/endo-123-4-2140

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  8 in total

Review 1.  Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential.

Authors:  Inga Herpfer; Klaus Lieb
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

2.  Substance P modulates the time course of nicotinic but not muscarinic catecholamine secretion from perfused adrenal glands of rat.

Authors:  X F Zhou; P D Marley; B G Livett
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

3.  Increased expression of preprotachykinin-I and neurokinin receptors in human breast cancer cells: implications for bone marrow metastasis.

Authors:  D Singh; D D Joshi; M Hameed; J Qian; P Gascón; P B Maloof; A Mosenthal; P Rameshwar
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

4.  Effect of capsaicin-sensitive sensory nerves on plasma glucose and catecholamine levels during 2-deoxyglucose-induced stress in conscious rats.

Authors:  X F Zhou; B G Livett
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

5.  Stress inhibits hair growth in mice by induction of premature catagen development and deleterious perifollicular inflammatory events via neuropeptide substance P-dependent pathways.

Authors:  Petra Clara Arck; Bori Handjiski; Eva Milena J Peters; Anita S Peter; Evelin Hagen; Axel Fischer; Burghard F Klapp; Ralf Paus
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

6.  Acute restraint stress activates functional NK1 receptor in the colon of female rats: involvement of steroids.

Authors:  S Bradesi; H Eutamene; J Fioramonti; L Bueno
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

7.  Capsaicin-sensitive sensory neurons are involved in the plasma catecholamine response of rats to selective stressors.

Authors:  X F Zhou; B G Livett
Journal:  J Physiol       Date:  1991-02       Impact factor: 5.182

Review 8.  Innovative approaches for the development of antidepressant drugs: current and future strategies.

Authors:  Lee E Schechter; Robert H Ring; Chad E Beyer; Zoë A Hughes; Xavier Khawaja; Jessica E Malberg; Sharon Rosenzweig-Lipson
Journal:  NeuroRx       Date:  2005-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.